0001213900-21-038633.txt : 20210726
0001213900-21-038633.hdr.sgml : 20210726
20210726161532
ACCESSION NUMBER: 0001213900-21-038633
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210715
FILED AS OF DATE: 20210726
DATE AS OF CHANGE: 20210726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gupta Shalabh K.
CENTRAL INDEX KEY: 0001864917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40582
FILM NUMBER: 211114314
MAIL ADDRESS:
STREET 1: UNICYCIVE THERAPEUTICS, INC.
STREET 2: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001766140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813638692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-384-0642
MAIL ADDRESS:
STREET 1: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-15
0
0001766140
Unicycive Therapeutics, Inc.
UNCY
0001864917
Gupta Shalabh K.
C/O UNICYCIVE THERAPEUTICS
LOS ALTOS
CA
94022
1
1
0
0
CEO
Stock Options
5.00
2021-07-15
4
A
0
116279
0
A
2031-07-15
Common Stock
116279
218023
D
The stock options vest equally over a period of three years from the date of grant.
/s/ Shalabh Gupta
2021-07-26